O
HELP

OrbiMed’s Helus Pharma Inc. Common Stock HELP Stock Holding History

OrbiMed’s Portfolio HELP Stock Details HELP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$21.6M Sell
3,271,400
-561,443
-15% -$2.81M 0.4% 64
2026
Q1 		$18.4M Sell
3,832,843
-7,657
-0.2% -$49.5K 0.36% 59
2025
Q4 		$31.4M Buy
+3,840,500
New +$24.7M 0.64% 47
2023
Q1 		– Sell
-141,745
Closed -$1.65M – 130
2022
Q4 		$1.65M Sell
141,745
-133,350
-48% -$2.2M 0.03% 106
2022
Q3 		$5.08M Sell
275,095
-1,860
-0.7% -$50.4K 0.09% 104
2022
Q2 		$5.89M Hold
276,955
– – 0.11% 107
2022
Q1 		$8.6M Hold
276,955
– – 0.14% 104
2021
Q4 		$12.5M Sell
276,955
-76,917
-22% -$4.87M 0.16% 108
2021
Q3 		$29.5M Buy
+353,872
New +$31M 0.32% 79

Other funds holding HELP

VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
DA
DCF Advisers Greenwich, Connecticut $566M AUM 197.74% 1-Year Est. Return
SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return
NFGH
Nan Fung Group Holdings Kai Tak, Hong Kong $131M AUM 86.64% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return

OrbiMed's HELP Position: Q2 2026 in Review

OrbiMed reduced its Helus Pharma Inc. Common Stock (HELP) stake by 15% in Q2 2026, selling an estimated $2.81M and leaving 3,271,400 shares worth $21.6M. The position accounts for 0.4% of the portfolio, ranked #64.

OrbiMed first reported a position in HELP in Q3 2021 and has held it in 9 quarters since. The position peaked at $31.4M in Q4 2025. 99 funds tracked by Wall St. Rank hold HELP as of Q2 2026.

  • OrbiMed held 3,271,400 shares of Helus Pharma Inc. Common Stock worth $21.6M as of Q2 2026.
  • OrbiMed sold 561,443 Helus Pharma Inc. Common Stock shares in Q2 2026, an estimated $2.81M.
  • Helus Pharma Inc. Common Stock made up 0.4% of OrbiMed's portfolio in Q2 2026, its #64 holding.
  • OrbiMed first reported a position in Helus Pharma Inc. Common Stock in Q3 2021 and has held it in 9 quarters since.
  • OrbiMed's Helus Pharma Inc. Common Stock position peaked at $31.4M in Q4 2025.
  • 99 funds tracked by Wall St. Rank held Helus Pharma Inc. Common Stock as of Q2 2026.

Based on OrbiMed's 13F filing for Q2 2026, filed 14 Aug 2026.